Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Home blood pressure measurement and digital health: communication technologies create a new context.

Postel-Vinay N, Bobrie G, Savard S, Persu A, Amar L, Azizi M, Parati G.

J Hypertens. 2018 Nov;36(11):2125-2131. doi: 10.1097/HJH.0000000000001860.

PMID:
30063638
2.

Sex differences in antihypertensive treatment in France among 17 856 patients in a tertiary hypertension unit.

Deborde T, Amar L, Bobrie G, Postel-Vinay N, Battaglia C, Tache A, Chedid A, Dhib MM, Chatellier G, Plouin PF, Burgun A, Azizi M, Jannot AS.

J Hypertens. 2018 Apr;36(4):939-946. doi: 10.1097/HJH.0000000000001607.

PMID:
29303829
3.

Cause of renal infarction: a retrospective analysis of 186 consecutive cases.

Faucon AL, Bobrie G, Jannot AS, Azarine A, Plouin PF, Azizi M, Amar L.

J Hypertens. 2018 Mar;36(3):634-640. doi: 10.1097/HJH.0000000000001588.

PMID:
29045340
4.

Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial.

Courand PY, Pereira H, Del Giudice C, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-Vehier C, Lantelme P, Denolle T, Dourmap C, Halimi JM, Girerd X, Rossignol P, Zannad F, Ormezzano O, Vaisse B, Herpin D, Ribstein J, Bouhanick B, Mourad JJ, Ferrari E, Chatellier G, Sapoval M, Azarine A, Azizi M; DENERHTN Investigators.

J Am Heart Assoc. 2017 Oct 10;6(10). pii: e007062. doi: 10.1161/JAHA.117.007062.

5.

[Text messaging and self-care support of hypertensive patients : first achievements].

Postel-Vinay N, Bobrie G, Amar L, Goumet J, Bernard M.

Rev Med Suisse. 2017 Sep 13;13(574):1566-1569. French.

PMID:
28905544
6.

Clinical and Genetic Spectrum of Bartter Syndrome Type 3.

Seys E, Andrini O, Keck M, Mansour-Hendili L, Courand PY, Simian C, Deschenes G, Kwon T, Bertholet-Thomas A, Bobrie G, Borde JS, Bourdat-Michel G, Decramer S, Cailliez M, Krug P, Cozette P, Delbet JD, Dubourg L, Chaveau D, Fila M, Jourde-Chiche N, Knebelmann B, Lavocat MP, Lemoine S, Djeddi D, Llanas B, Louillet F, Merieau E, Mileva M, Mota-Vieira L, Mousson C, Nobili F, Novo R, Roussey-Kesler G, Vrillon I, Walsh SB, Teulon J, Blanchard A, Vargas-Poussou R.

J Am Soc Nephrol. 2017 Aug;28(8):2540-2552. doi: 10.1681/ASN.2016101057. Epub 2017 Apr 5.

7.

Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).

Gosse P, Cremer A, Pereira H, Bobrie G, Chatellier G, Chamontin B, Courand PY, Delsart P, Denolle T, Dourmap C, Ferrari E, Girerd X, Michel Halimi J, Herpin D, Lantelme P, Monge M, Mounier-Vehier C, Mourad JJ, Ormezzano O, Ribstein J, Rossignol P, Sapoval M, Vaïsse B, Zannad F, Azizi M.

Hypertension. 2017 Mar;69(3):494-500. doi: 10.1161/HYPERTENSIONAHA.116.08448. Epub 2017 Jan 23.

PMID:
28115517
8.

Copeptin is increased in resistant hypertension.

Mendes M, Dubourg J, Blanchard A, Bergerot D, Courand PY, Forni V, Frank M, Bobrie G, Menard J, Azizi M.

J Hypertens. 2016 Dec;34(12):2458-2464.

PMID:
27755389
9.

[Towards new targets in the treatment of hypertension?]

Faucon AL, Madjalian AM, Bobrie G, Amar L, Azizi M.

Med Sci (Paris). 2016 Oct;32(10):861-866. Epub 2016 Oct 19. French.

10.

Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.

Azizi M, Pereira H, Hamdidouche I, Gosse P, Monge M, Bobrie G, Delsart P, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Girerd X, Michel Halimi J, Zannad F, Ormezzano O, Vaïsse B, Herpin D, Ribstein J, Chamontin B, Mourad JJ, Ferrari E, Plouin PF, Jullien V, Sapoval M, Chatellier G; DENERHTN Investigators.

Circulation. 2016 Sep 20;134(12):847-57. doi: 10.1161/CIRCULATIONAHA.116.022922. Epub 2016 Aug 30.

PMID:
27576780
11.

[Fibromuscular dysplasia of renal arteries].

Plouin PF, Fiquet B, Bobrie G, Jeunemaître X.

Nephrol Ther. 2016 Apr;12 Suppl 1:S135-8. doi: 10.1016/j.nephro.2016.02.011. Epub 2016 Mar 8. French.

PMID:
26968476
12.

Automated interpretation of home blood pressure assessment (Hy-Result software) versus physician's assessment: a validation study.

Postel-Vinay N, Bobrie G, Ruelland A, Oufkir M, Savard S, Persu A, Katsahian S, Plouin PF.

Blood Press Monit. 2016 Apr;21(2):111-7. doi: 10.1097/MBP.0000000000000162.

PMID:
26544522
13.

Renal denervation for resistant hypertension - Authors' reply.

Azizi M, Pereira H, Bobrie G, Gosse P, Chatellier G; Renal Denervation for Hypertension (DENERHTN) investigators.

Lancet. 2015 Sep 26;386(10000):1240. doi: 10.1016/S0140-6736(15)00259-7. No abstract available.

PMID:
26460654
14.

True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence.

Beaussier H, Boutouyrie P, Bobrie G, Frank M, Laurent S, Coudoré F, Azizi M.

J Hypertens. 2015 Dec;33(12):2526-33. doi: 10.1097/HJH.0000000000000737.

PMID:
26378683
15.

Deciphering the Role of Vasopressin in Primary Aldosteronism.

Nogueira-Silva L, Blanchard A, Curis E, Lorthioir A, Zhygalina V, Bergerot D, Baron S, Amar L, Bobrie G, Plouin PF, Ménard J, Azizi M.

J Clin Endocrinol Metab. 2015 Sep;100(9):3297-303. doi: 10.1210/JC.2015-2007. Epub 2015 Jul 10.

PMID:
26161452
16.

Sarcoidosis presenting as severe renin-dependent hypertension due to kidney vascular injury.

Rafat C, Bobrie G, Chedid A, Nochy D, Hernigou A, Plouin PF.

Clin Kidney J. 2014 Aug;7(4):383-6. doi: 10.1093/ckj/sfu060. Epub 2014 Jun 23.

17.

Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.

Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF, Chatellier G; Renal Denervation for Hypertension (DENERHTN) investigators.

Lancet. 2015 May 16;385(9981):1957-65. doi: 10.1016/S0140-6736(14)61942-5. Epub 2015 Jan 26.

PMID:
25631070
18.

Greater efficacy of aldosterone blockade and diuretic reinforcement vs. dual renin-angiotensin blockade for left ventricular mass regression in patients with resistant hypertension.

Azizi M, Perdrix L, Bobrie G, Frank M, Chatellier G, Ménard J, Plouin PF.

J Hypertens. 2014 Oct;32(10):2038-44; discussion 2044. doi: 10.1097/HJH.0000000000000280.

PMID:
24983187
19.

Eligibility for renal denervation: anatomical classification and results in essential resistant hypertension.

Okada T, Pellerin O, Savard S, Curis E, Monge M, Frank M, Bobrie G, Yamaguchi M, Sugimoto K, Plouin PF, Azizi M, Sapoval M.

Cardiovasc Intervent Radiol. 2015 Feb;38(1):79-87. doi: 10.1007/s00270-014-0865-6. Epub 2014 Mar 6.

PMID:
24595661
20.

[Masked hypertension].

Bobrie G.

Bull Acad Natl Med. 2014 Jan;198(1):55-8; discussion 58-60. French.

PMID:
26259286

Supplemental Content

Loading ...
Support Center